GlassScriptPhysician profile
Larry J Diaz
NPI 1952301038
$32,719.74
in general payments reported to CMS, 2019-2025
49 companies · $1,876 in 2025
The $1,876 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $6,689 · 2021: $1,800 · 2022: $4,550 · 2023: $2,055 · 2024: $5,534 · 2025: $1,876.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,040 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,039.68 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,425.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $12,692.15 | 2019-2025 | Indigo System, Ruby Coil |
| Cook Incorporated | $9,005.00 | 2020-2024 | Rosen |
| Medicure Pharma INC. | $1,600.00 | 2020-2021 | |
| Boston Scientific Corporation | $1,030.70 | 2019-2025 | Ekosonic, General - Thrombectomy, Watchman Access System |
| Abiomed | $855.35 | 2021-2024 | Impella |
| Abbott Laboratories | $727.56 | 2019-2025 | Amplatzer Amulet, Optis, Amplatzer Talisman |
| Medtronic, INC. | $678.43 | 2022-2025 | Symplicity G3, Corevalve Evolut R |
| Cardiva Medical, INC. | $514.93 | 2023-2024 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Shockwave Medical, INC | $509.59 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $499.58 | 2021-2025 | Lifevest |
| Inari Medical, INC. | $495.56 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novartis Pharmaceuticals Corporation | $483.87 | 2021-2025 | |
| Stryker Corporation | $418.66 | 2025 | Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Edwards Lifesciences Corporation | $385.60 | 2022-2025 | Sapien 3 Ultra Resilia |
| Janssen Pharmaceuticals, INC | $383.88 | 2021-2024 | Xarelto |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cordis US Corp. | $290.60 | 2022-2025 | Mynxgrip, Radial 360 |
| Pfizer INC. | $201.89 | 2024-2025 | |
| Siemens Medical Solutions USA, INC. | $191.11 | 2020 | |
| Devoro Medical INC. | $154.06 | 2021 | |
| Ekos Corporation | $145.33 | 2019 | |
| Kestra Medical Technology Services, INC. | $137.92 | 2024 | Assure Wcd |
| Biocompatibles, INC. | $125.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $115.89 | 2023-2025 | Eliquis, Camzyos |
| Cook Medical LLC | $110.39 | 2020 | |
| Chiesi USA, INC. | $106.72 | 2023-2025 | Kengreal, Cleviprex |
| Amgen INC. | $106.70 | 2023 | Repatha |
| Biotronik INC. | $101.76 | 2022 | |
| Corindus INC. | $91.02 | 2019 | |
| Cardiovascular Systems INC. | $70.56 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $66.47 | 2022 | |
| Terumo Medical Corporation | $66.47 | 2021 | |
| Heartflow, INC. | $48.76 | 2023-2025 | Ffrct |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.72 | 2025 | Jardiance |
| Angiodynamics, INC. | $34.66 | 2024 | Alphavac |
| Imperative Care, INC | $30.50 | 2024 | Symphony Catheter |
| Atricure, INC. | $26.76 | 2025 | Atriclip Laa Exclusion System |
| Alnylam Pharmaceuticals INC. | $24.36 | 2025 | Onpattro |
| Becton, Dickinson and Company | $22.21 | 2025 | Rotarexs 6 F X 135 Cm |
| W. L. Gore & Associates, INC. | $21.20 | 2024 | Gore Excluder Aaa Endoprosthesis |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $20.00 | 2021 | |
| Teleflex LLC | $19.67 | 2023 | Manta |
| Lexicon Pharmaceuticals, INC. | $18.42 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.99 | 2025 | |
| Avinger INC. | $15.26 | 2020 | |
| Glaxosmithkline, LLC. | $14.48 | 2025 | Shingrix, Arexvy |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$8,950.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$100,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Diaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.